Themis Medicare Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹76.53 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 15.09 per cent from ₹90.13 crore. This corresponds to a year-on-year *(YoY) growth of 6.74 per cent.
Operating Profit
Operating Profit stands at ₹3.76 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 57.89 per cent from ₹8.93 crore. This corresponds to a year-on-year *(YoY) growth of 148.83 per cent.
PBDT
PBDT stands at ₹11.66 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 10.10 per cent from ₹12.97 crore. This corresponds to a year-on-year *(YoY) growth of 235.74 per cent.
Profit Before Tax
Profit Before Tax stands at ₹9.06 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.72 per cent from ₹10.38 crore. This corresponds to a year-on-year *(YoY) growth of 181.47 per cent.
Net Profit
Net Profit stands at ₹8.89 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.89 per cent from ₹10.09 crore. This represents a 192.03 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Themis Medicare Ltd Earnings
- YOY
- QOQ
Themis Medicare Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Themis Medicare Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Themis Medicare Ltd Financial Reports
Themis Medicare Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Themis Medicare | 5.21% | 1.45% | -4.03% | 13.84% | 23.12% | 10.56% |
| Lincoln Pharma. | 3.15% | 0.86% | 0.71% | -8.17% | -1.91% | 12.25% |
| Bajaj Healthcare | 2.62% | 2.25% | -2.98% | 14.80% | -6.26% | -26.15% |
| Sigachi Indust. | 2.06% | 7.16% | 15.77% | 29.34% | 21.93% | -11.15% |
| Bharat Parenter. | -0.36% | 0.00% | -0.29% | 13.18% | 29.53% | -3.15% |
| Wanbury | -0.98% | 1.51% | -23.03% | 0.94% | 2.70% | 2.64% |
| Kopran | 2.76% | -1.32% | -13.73% | 13.33% | 33.78% | 13.80% |
Company Info
Company Information
Chairman & Exec. Director : Dinesh S Patel
ED / MD / CEO / Promoter : Sachin D Patel
Non-Exec & Non-Independent Dir : Reena S Patel
Non-Exec & Non-Independent Dir : Rajneesh Anand
Non-Exec & Non-Independent Dir : Adam Demeter
Independent Non Exe. Director : Bhaskar Vemban Iyer
Independent Non Exe. Director : Shishir Dalal
Independent Non Exe. Director : Nikunt Raval
Independent Director : Neha Thakore